Related Experiment Video
Updated: Jun 11, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Longitudinal Outcomes Following Mitral Valve Repair for Infective Endocarditis
Yuan Qiu1, Lawrence Lau2, Zaim Khan1
1Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, ON K1Y 4W7, Canada.
Abstract:
Mitral valve repair is the ideal approach in managing mitral valve infective endocarditis for patients requiring surgery. However, viable repair is influenced by the extent of valve destruction and there can be technical challenges in reconstruction following debridement. Overall, data describing long-term outcomes following mitral repair of infective endocarditis are scarce. We, therefore, assessed the late outcomes of 101 consecutive patients who underwent mitral valve repair for IE at the University of Ottawa Heart Institute from 2001 to 2021. The 5- and 10-year survival rate was 80.8 ± 4.7% and 61.2 ± 9.2%, respectively. Among these 101 patients, 7 ultimately required mitral valve reoperation at a median of 5 years after their initial operation. These patients were of a mean age of 35.9 ± 7.3 years (range 22-44 years) at the time of their initial operation. The 5- and 10-year freedom from mitral valve reoperation was 93.6 ± 3.4% and 87.7 ± 5.2%, respectively. Overall, mitral valve repair can be an effective method for treating infective endocarditis with a favourable freedom from reoperation and mortality over the long term.
Insights
Mitral valve repair is effective for infective endocarditis, showing good long-term survival and low reoperation rates in a recent study. This surgical approach offers a favorable outlook for patients needing valve intervention.
Area of Science:
- Cardiology
- Cardiac Surgery
- Infectious Diseases
Background:
- Mitral valve repair is the preferred surgical method for infective endocarditis.
- Challenges exist in valve reconstruction after debridement due to extensive destruction.
- Limited data exists on the long-term results of mitral valve repair for infective endocarditis.
Purpose of the Study:
- To evaluate the long-term outcomes of mitral valve repair in patients with infective endocarditis.
- To assess survival rates and freedom from reoperation after mitral valve repair for infective endocarditis.
Main Methods:
- Retrospective analysis of 101 consecutive patients undergoing mitral valve repair for infective endocarditis.
- Data collected from the University of Ottawa Heart Institute between 2001 and 2021.
- Evaluation of survival and reoperation rates at 5 and 10 years post-surgery.
Main Results:
- The 5- and 10-year survival rates were 80.8% and 61.2%, respectively.
- Seven patients (approximately 6.9%) required mitral valve reoperation at a median of 5 years.
- The 5- and 10-year freedom from mitral valve reoperation was 93.6% and 87.7%, respectively.
Conclusions:
- Mitral valve repair is an effective treatment for infective endocarditis.
- The procedure demonstrates favorable long-term freedom from reoperation and mortality.
- Mitral valve repair offers a viable surgical option for selected patients with infective endocarditis.
Related Concept Videos
Endocarditis III: Medical Management
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation III: Medical Management
Mitral Regurgitation II: Clinical features and Diagnostic Tests

